These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8324129)

  • 1. Empyema due to Bacteroides gracilis: case report and in vitro susceptibilities to eight antimicrobial agents.
    Lee D; Goldstein EJ; Citron DM; Ross S
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S263-5. PubMed ID: 8324129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
    Bandoh K; Ueno K; Watanabe K; Kato N
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of selected antimicrobial agents against Bilophila wadsworthia and Bacteroides gracilis.
    Baron EJ; Ropers G; Summanen P; Courcol RJ
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S339-43. PubMed ID: 8324144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary.
    Sárvári KP; Sóki J; Kristóf K; Juhász E; Miszti C; Latkóczy K; Melegh SZ; Urbán E
    Infect Dis (Lond); 2018 May; 50(5):372-380. PubMed ID: 29303023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Bacteroides isolates recovered among clinical samples from a major Costa Rican hospital between 2000 and 2008 to ß-lactams, clindamycin, metronidazole, and chloramphenicol.
    Cordero-Laurent E; Rodríguez C; Rodríguez-Cavallini E; Gamboa-Coronado MM; Quesada-Gómez C
    Rev Esp Quimioter; 2012 Dec; 25(4):261-5. PubMed ID: 23303257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
    Cáceres M; Carera E; Palmgren AC; Nord CE
    Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
    Borobio MV; Domínguez MC; Pallares JA; Perea EJ
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of tigecycline against Bacteroides species.
    Betriu C; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
    J Antimicrob Chemother; 2005 Aug; 56(2):349-52. PubMed ID: 15951353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.
    Snydman DR; McDermott L; Cuchural GJ; Hecht DW; Iannini PB; Harrell LJ; Jenkins SG; O'Keefe JP; Pierson CL; Rihs JD; Yu VL; Finegold SM; Gorbach SL
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S54-65. PubMed ID: 8953108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.
    Snydman DR; Jacobus NV; McDermott LA; Goldstein EJ; Harrell L; Jenkins SG; Newton D; Patel R; Hecht DW
    Anaerobe; 2017 Feb; 43():21-26. PubMed ID: 27867083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Bacteroides from swine abscesses to 13 antibiotics.
    Benno Y; Mitsuoka T
    Am J Vet Res; 1984 Dec; 45(12):2631-3. PubMed ID: 6524756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of Bacteroides species to modern antimicrobial preparations.
    Závadová M; Tynková S; Adensámová J; Brezinová L
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):51-9. PubMed ID: 6602163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains.
    Boente RF; Ferreira LQ; Falcão LS; Miranda KR; Guimarães PL; Santos-Filho J; Vieira JM; Barroso DE; Emond JP; Ferreira EO; Paula GR; Domingues RM
    Anaerobe; 2010 Jun; 16(3):190-4. PubMed ID: 20159050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The first metronidazole-resistant Bacteroides species isolated at Marmara University Hospital: Bacteroides thetaiotaomicron].
    Toprak Ülger N; Sayın E; Soyad A; Dane F; Söyletir G
    Mikrobiyol Bul; 2013 Oct; 47(4):717-21. PubMed ID: 24237441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole- and carbapenem-resistant bacteroides thetaiotaomicron isolated in Rochester, Minnesota, in 2014.
    Sadarangani SP; Cunningham SA; Jeraldo PR; Wilson JW; Khare R; Patel R
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4157-61. PubMed ID: 25941219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
    Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y
    Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of cefoxitin vs. cefotetan against clinical isolates of Bacteroides and Prevotella species.
    Grossmeyer TJ; Farmer SG
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S353-6. PubMed ID: 8324146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.